Detection of In Vivo Mutation in the Hprt and Pig-a Genes of Rat Lymphocytes.

Methods Mol Biol

Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, USA.

Published: April 2020

Assays for in vivo mutation are used to identify genotoxic hazards and phenotypes prone to genomic instability and cancer. The hypoxanthine guanine phosphoribosyl transferase (Hprt) gene and the phosphatidyl inositol glycan, class A (Pig-a) gene are endogenous X-linked genes that can be used as reporters of mutation in peripheral blood lymphocytes from most mammals. Here we describe methodology for measuring Hprt and Pig-a mutation in rat T-lymphocytes. The identification and selective expansion of mutant lymphocytes is based upon the phenotypic properties of Hprt- and Pig-a-deficient cells, that is, resistance to the purine analog, 6-thioguanine, or to the bacterial toxin, proaerolysin. Expanded mutants can be further analyzed by sequencing cDNA from the target transcripts for identification of small sequence alterations and by multiplex PCR analysis of genomic DNA for the detection of deletions.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-9646-9_3DOI Listing

Publication Analysis

Top Keywords

vivo mutation
8
hprt pig-a
8
detection vivo
4
mutation
4
mutation hprt
4
pig-a genes
4
genes rat
4
rat lymphocytes
4
lymphocytes assays
4
assays vivo
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!